Aclaris Therapeutics to Announce First Quarter 2017 Financial Results on May 9, 2017
May 09 2017 - 5:48PM
Aclaris Therapeutics, Inc. (NASDAQ:ACRS)
Due to technical difficulties experienced by NASDAQ during
today’s call, management has rescheduled its conference call for
6:00 PM ET today to discuss the Company’s financial results
and provide a general business update. The conference will be
webcast live over the Internet and can be accessed by logging on to
the “Investors” section of the Aclaris Therapeutics
website, www.aclaristx.com, prior to the event. A replay
of the webcast will be archived on the Company’s website for 30
days following the call.
To participate on the live call, please dial (844) 776-7782
(domestic) or (661) 378-9535 (international), and reference
conference ID 5101760 prior to the start of the
call.
About Aclaris
Aclaris Therapeutics, Inc. is a clinical-stage dermatologist-led
biotechnology company focused on identifying, developing and
commercializing innovative and differentiated therapies to address
significant unmet needs in medical and aesthetic dermatology.
Aclaris is based in Malvern, Pennsylvania and more information can
be found by visiting the Aclaris website at www.aclaristx.com.
Contact:
Aclaris Contact
Michael Tung, M.D.
Investor Relations
484-329-2140
mtung@aclaristx.com
Media Contact
Mariann Caprino
TogoRun
917-242-1087
M.Caprino@togorun.com
Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Sep 2023 to Sep 2024